Zhongxing BioTech: Recently, there have been no significant changes in the company's operating conditions or the internal and external operating environment

Zhongxing BioTech announced on September 14th that the cumulative price deviation of its stock closing price has exceeded 20% over three consecutive trading days. According to the relevant regulations of the Shenzhen Stock Exchange, this constitutes an abnormal fluctuation in stock trading. After verification, the company confirmed that there are no corrections or supplements needed for the information previously disclosed. The company has not found any recent public media reports that may have significantly impacted the trading price of its stock due to undisclosed material information. Recently, the company's operating conditions and internal and external business environment have not undergone significant changes, and internal production and operational activities are proceeding normally. The company, its controlling shareholders, and actual controllers do not have any significant matters that should be disclosed but have not been disclosed, nor are there any significant matters in the planning stage. During the period of abnormal fluctuations in stock trading, the controlling shareholders and actual controllers did not engage in buying or selling the company's stock